Corza Medical Completes Acquisition of TachoSil Manufacturing Operations
July 01 2024 - 7:57AM
Corza Medical successfully closed its previously
announced acquisition of the TachoSil manufacturing operations in
Linz, Austria, part of Takeda’s global production network.
TachoSil is a best-in-class surgical patch trusted
by medical professionals across the
globe. Corza Medical acquired the
commercial rights for TachoSil in January 2021.
The acquisition of the manufacturing operations will enable Corza
Medical to further deliver exceptional value to its customers by
combining operational excellence with its commercial excellence
engine. It will also allow the company to control manufacturing
priorities directly, accelerating enhanced service levels and
support to customers globally. “The
acquisition of TachoSil manufacturing operations marks a
significant milestone for Corza Medical. We are excited to have
completed the acquisition successfully and welcome the employees
transferring from Takeda," said
Tom Testa, CEO of
Corza Medical. "This acquisition will enable us to enhance our
product offerings and better serve our customers. We are committed
to investing in TachoSil to improve patient care and deliver
innovative solutions to surgeons
worldwide.” Executive Chairman
Gregory T. Lucier of Corza Medical added, "The
investment to own the TachoSil manufacturing operations in Linz
will help streamline the supply chain and build a stronger
operational capability for our Biosurgery business. We are
confident that with the Linz facilities as part of our operations,
we will enhance the support for our customers and further deliver
on Corza's brand promise of remarkable service, trusted
performance, and outstanding value to meet the needs of healthcare
professionals." "By taking ownership
of the entire manufacturing process, we will be able to accelerate
our growth by increasing our manufacturing capacity and serving new
countries. We are excited to advance patient care everywhere in the
world,” said
Thierry Leclercq Corza Medical’s SVP,
GM Biosurgery. Corza Medical is a
portfolio company of GTCR, a leading private equity firm, which
helped create and build the business in partnership with Gregory T.
Lucier. With a focused commitment to remarkable service, trusted
performance, and outstanding economic value to customers, Corza
Medical has the experience and resources to continue investing in
TachoSil for the benefit of its surgeons, partners, and patients
around the world.
About Corza
Medical Corza Medical is a leading global
manufacturer of innovative surgical technologies. With a global
team of over 3,000 employees supporting clinicians,
distributor-partners, and medical device companies worldwide, Corza
provides healthcare professionals a platform of surgical
technologies with many industry-leading brands, including Quill®
barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena®
reusable and Blink™ single-use ophthalmic instruments, Barron
corneal transplant devices, Sharpoint® microsurgical knives, and
the TachoSil® fibrin sealant patch. For more information, please
visit www.corza.com.
About
GTCR Founded in 1980, GTCR is a leading private
equity firm that pioneered The Leaders Strategy™ – finding and
partnering with management leaders in core domains to identify,
acquire and build market-leading companies through organic growth
and strategic acquisitions. GTCR is focused on investing in
transformative growth in companies in the Business & Consumer
Services, Financial Services & Technology, Healthcare and
Technology, Media & Telecommunications sectors. Since its
inception, GTCR has invested more than $25 billion in over 270
companies, and the firm currently manages more than $40 billion in
equity capital. GTCR is based in Chicago with offices in New York
and West Palm Beach. For more information, please
visit www.gtcr.com. Follow us on LinkedIn.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/3b1335ed-d9ff-41b3-8bfa-81535087cd22
Media Contact
Luci Curi—Director, Communications and PR
media@corza.com